Effects of Glucose Insulin Potassium infusion on inflammatory markers in patients with acute heart failure
Phase 2
- Conditions
- Acute heart failure.Heart failure, unspecified
- Registration Number
- IRCT201111238185N1
- Lead Sponsor
- Vice chancellor for research and technology, Kermanshah university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Inclusion criterias: All patients presenting as acute heart failure with left ventricular ejection fraction (LVEF) < 40%
Exclusion criterias: LVEF>40; Diabetes mellitus; Hypoglycemia; hyperkalemia; High Hs-CRP states including Infectious and Rheumatic diseases, cancers, Tissue damages, Burns and inflammatory bowel diseases.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hs-CRP. Timepoint: Before GIK administration, at 3rd and 5th days after GIK administration. Method of measurement: Blood test.;Nt Pro BNP. Timepoint: Before GIK administration, at 3rd and 5th days after GIK administration. Method of measurement: Blood test.
- Secondary Outcome Measures
Name Time Method Inhospital death. Timepoint: During hospital-stay period. Method of measurement: On the basis of vital sign.;Ventricular arrhythmias. Timepoint: During hospital-stay period. Method of measurement: On the basis of cardiac monitoring.